227 related articles for article (PubMed ID: 9583849)
1. Biochemical assessment of the nutritional status of cystic fibrosis patients treated with pancreatic enzyme extracts.
Benabdeslam H; Garcia I; Bellon G; Gilly R; Revol A
Am J Clin Nutr; 1998 May; 67(5):912-8. PubMed ID: 9583849
[TBL] [Abstract][Full Text] [Related]
2. Influence of lyophilized total pancreas on plasma lipids and on fat absorption in cystic fibrosis.
Malmendier CL; Van Den Bergen CJ; Baran D
Helv Paediatr Acta; 1977 Jul; 32(2):115-28. PubMed ID: 617969
[TBL] [Abstract][Full Text] [Related]
3. Retinol binding protein status in relation to ocular surface changes in patients with cystic fibrosis treated with daily vitamin A supplements.
Mrugacz M; Tobolczyk J; Minarowska A
Eur J Pediatr; 2005 Apr; 164(4):202-6. PubMed ID: 15789254
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid pool size in plasma lipoprotein fractions of cystic fibrosis patients.
Clandinin MT; Zuberbuhler P; Brown NE; Kielo ES; Goh YK
Am J Clin Nutr; 1995 Dec; 62(6):1268-75. PubMed ID: 7491891
[TBL] [Abstract][Full Text] [Related]
5. Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation.
Lloyd-Still JD; Johnson SB; Holman RT
Am J Clin Nutr; 1981 Jan; 34(1):1-7. PubMed ID: 7446449
[TBL] [Abstract][Full Text] [Related]
6. Status of plasma and erythrocyte fatty acids and vitamin A and E in young children with cystic fibrosis.
Biggemann B; Laryea MD; Schuster A; Griese M; Reinhardt D; Bremer HJ
Scand J Gastroenterol Suppl; 1988; 143():135-41. PubMed ID: 3164500
[TBL] [Abstract][Full Text] [Related]
7. Effect of administration of gamma-linolenic acid on the fatty acid composition of serum phospholipids and cholesteryl esters in patients with cystic fibrosis.
Christophe A; Robberecht E; Franckx H; De Baets F; van de Pas M
Ann Nutr Metab; 1994; 38(1):40-7. PubMed ID: 8185286
[TBL] [Abstract][Full Text] [Related]
8. Deficiencies of essential fatty acids and vitamin E in cystic fibrosis.
Böhles H; Heid H; Stehr K; Fekl W
Z Ernahrungswiss; 1979 Jul; 18(2):81-7. PubMed ID: 524930
[TBL] [Abstract][Full Text] [Related]
9. Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns.
Sokol RJ; Reardon MC; Accurso FJ; Stall C; Narkewicz M; Abman SH; Hammond KB
Am J Clin Nutr; 1989 Nov; 50(5):1064-71. PubMed ID: 2816791
[TBL] [Abstract][Full Text] [Related]
10. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids.
Kalivianakis M; Minich DM; Bijleveld CM; van Aalderen WM; Stellaard F; Laseur M; Vonk RJ; Verkade HJ
Am J Clin Nutr; 1999 Jan; 69(1):127-34. PubMed ID: 9925134
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)].
Gottschalk B; Wiesemann HG; Stephan U
Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients.
Wood LG; Fitzgerald DA; Gibson PG; Cooper DM; Garg ML
Am J Clin Nutr; 2002 Apr; 75(4):668-75. PubMed ID: 11916752
[TBL] [Abstract][Full Text] [Related]
13. Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum lipids in patients with cystic fibrosis.
Rettammel AL; Marcus MS; Farrell PM; Sondel SA; Koscik RE; Mischler EH
J Am Diet Assoc; 1995 Apr; 95(4):454-9. PubMed ID: 7699188
[TBL] [Abstract][Full Text] [Related]
14. Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals.
Winklhofer-Roob BM; Tuchschmid PE; Molinari L; Shmerling DH
Am J Clin Nutr; 1996 May; 63(5):717-21. PubMed ID: 8615354
[TBL] [Abstract][Full Text] [Related]
15. [Clinical trial of several preparation types of the pancreatic extract Pancrex V in the treatment of cystic fibrosis].
Braggion C; Mastella G
Minerva Pediatr; 1985 Nov; 37(21-22):891-6. PubMed ID: 3912659
[No Abstract] [Full Text] [Related]
16. Abnormal fatty acid pattern of the plasma cholesterol ester fraction in cystic fibrosis patients with and without pancreatic insufficiency.
Rogiers V; Vercruysse A; Dab I; Baran D
Eur J Pediatr; 1983 Oct; 141(1):39-42. PubMed ID: 6641763
[TBL] [Abstract][Full Text] [Related]
17. Vitamin A absorption in cystic fibrosis: risk of hypervitaminosis A.
James DR; Owen G; Campbell IA; Goodchild MC
Gut; 1992 May; 33(5):707-10. PubMed ID: 1612491
[TBL] [Abstract][Full Text] [Related]
18. [Selenium and vitamin E in mucoviscidosis].
Foucaud P; Thérond P; Marchand M; Brion F; Demelier JF; Navarro J
Arch Fr Pediatr; 1988; 45(6):383-6. PubMed ID: 3219038
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of enteric-coated preparations on nutritional parameters in cystic fibrosis. A long-term study.
Carroccio A; Pardo F; Montalto G; Japichino L; Iacono G; Collura M; Notarbartolo A
Digestion; 1988; 41(4):201-6. PubMed ID: 3243379
[TBL] [Abstract][Full Text] [Related]
20. Vitamin A status in acute exacerbations of cystic fibrosis.
Duggan C; Colin AA; Agil A; Higgins L; Rifai N
Am J Clin Nutr; 1996 Oct; 64(4):635-9. PubMed ID: 8839511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
